Bridger Management, LLC Bio Techne Corp Transaction History

Bridger Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $1.69 Million - $2.36 Million	-5,242 Reduced 78.4%	1,444 $501,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $178,340 - $245,846	-504 Reduced 7.01%	6,686 $2.9 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $3.2 Million - $3.87 Million	7,190 New	7,190 $3.48 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.